Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer

Abstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photosta...

Full description

Bibliographic Details
Main Authors: Peili Cen, Jiani Huang, Chentao Jin, Jing Wang, Yen Wei, Hong Zhang, Mei Tian
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Aggregate
Subjects:
Online Access:https://doi.org/10.1002/agt2.352
_version_ 1827787530382082048
author Peili Cen
Jiani Huang
Chentao Jin
Jing Wang
Yen Wei
Hong Zhang
Mei Tian
author_facet Peili Cen
Jiani Huang
Chentao Jin
Jing Wang
Yen Wei
Hong Zhang
Mei Tian
author_sort Peili Cen
collection DOAJ
description Abstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer.
first_indexed 2024-03-11T16:51:11Z
format Article
id doaj.art-39460f67a61c4ea5989f2e3c50965a61
institution Directory Open Access Journal
issn 2692-4560
language English
last_indexed 2024-03-11T16:51:11Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Aggregate
spelling doaj.art-39460f67a61c4ea5989f2e3c50965a612023-10-21T07:53:27ZengWileyAggregate2692-45602023-10-0145n/an/a10.1002/agt2.352Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancerPeili Cen0Jiani Huang1Chentao Jin2Jing Wang3Yen Wei4Hong Zhang5Mei Tian6Department of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Chemistry and the Tsinghua Center for Frontier Polymer Research Tsinghua University Beijing ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Nuclear Medicine and PET Center The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaAbstract Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer.https://doi.org/10.1002/agt2.352aggregation‐induced emissioncancernear‐infrared imagingphototherapytargeting strategytheranostics
spellingShingle Peili Cen
Jiani Huang
Chentao Jin
Jing Wang
Yen Wei
Hong Zhang
Mei Tian
Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
Aggregate
aggregation‐induced emission
cancer
near‐infrared imaging
phototherapy
targeting strategy
theranostics
title Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
title_full Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
title_fullStr Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
title_full_unstemmed Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
title_short Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
title_sort aggregation induced emission luminogens for in vivo molecular imaging and theranostics in cancer
topic aggregation‐induced emission
cancer
near‐infrared imaging
phototherapy
targeting strategy
theranostics
url https://doi.org/10.1002/agt2.352
work_keys_str_mv AT peilicen aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT jianihuang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT chentaojin aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT jingwang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT yenwei aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT hongzhang aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer
AT meitian aggregationinducedemissionluminogensforinvivomolecularimagingandtheranosticsincancer